Cellular Biomedicine (CBMG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CBMG | AZN | AMGN | GILD | VRTX |
| Company | Cellular Biomedicine | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 19.74 | 157.68 | 413.31 | 133.99 | 527.00 |
| High | 19.75 | 159.02 | 418.19 | 137.12 | 531.22 |
| Low | 19.73 | 157.12 | 409.00 | 133.29 | 520.08 |
| Last | 19.75 | 158.50 | 416.18 | 135.87 | 525.73 |
| Change | unch | -0.25 | +1.88 | +0.10 | -3.92 |
| Percent Change | unch | -0.16% | +0.45% | +0.07% | -0.74% |
| Volume | 171,900 | 4,139,572 | 2,065,525 | 5,683,830 | 1,046,924 |
| 20-Day Average Volume | 197,580 | 3,926,869 | 2,728,991 | 7,063,156 | 1,385,496 |
| Previous | 19.75 | 158.75 | 414.30 | 135.77 | 529.65 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 19.27 | 165.62 | 387.59 | 132.53 | 488.12 |
| 20-Day Raw Stochastic | 99.77% | 23.53% | 91.24% | 63.54% | 74.82% |
| 20-Day Relative Strength | 67.50 | 38.39 | 69.67 | 55.93 | 65.62 |
| Weighted Alpha | +21.75 | -9.06 | +45.26 | +13.57 | +36.09 |
| Today's Opinion | 100% Buy | 100% Sell | 100% Buy | 56% Buy | 100% Buy |
| Yesterday's Opinion | 100% Buy | 100% Sell | 100% Buy | 40% Buy | 100% Buy |
| Last Month's Opinion | 8% Sell | 88% Sell | 56% Buy | 40% Sell | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.10% since 02/11/21 | -1.86% since 08/05/26 | +2.05% since 08/05/26 | +3.12% since 08/05/26 | +8.44% since 08/05/26 |
| Low | 19.68 on 02/12/21 | 157.12 on 08/12/26 | 401.07 on 08/07/26 | 129.02 on 08/06/26 | 480.86 on 08/06/26 |
| High | 19.75 on 02/18/21 | 162.93 on 08/06/26 | 421.79 on 08/11/26 | 137.12 on 08/12/26 | 546.17 on 08/10/26 |
| 1-Month | |||||
| %Chg | +8.76% since 01/19/21 | -7.64% since 07/10/26 | +14.53% since 07/10/26 | +4.65% since 07/10/26 | +8.31% since 07/10/26 |
| Low | 17.60 on 01/28/21 | 153.41 on 08/03/26 | 353.95 on 07/15/26 | 127.61 on 07/23/26 | 465.00 on 07/23/26 |
| High | 19.75 on 02/18/21 | 175.04 on 07/29/26 | 421.79 on 08/11/26 | 140.61 on 07/17/26 | 546.17 on 08/10/26 |
| 3-Month | |||||
| %Chg | +7.63% since 11/19/20 | -14.11% since 05/12/26 | +23.76% since 05/12/26 | +0.69% since 05/12/26 | +17.27% since 05/12/26 |
| Low | 17.60 on 01/28/21 | 153.41 on 08/03/26 | 320.96 on 05/19/26 | 121.39 on 06/10/26 | 420.01 on 06/03/26 |
| High | 19.75 on 02/18/21 | 196.41 on 07/02/26 | 421.79 on 08/11/26 | 140.61 on 07/17/26 | 546.17 on 08/10/26 |
| 6-Month | |||||
| %Chg | +7.57% since 08/19/20 | -22.50% since 02/12/26 | +13.65% since 02/12/26 | -10.50% since 02/12/26 | +13.06% since 02/12/26 |
| Low | 16.98 on 11/06/20 | 153.41 on 08/03/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 412.27 on 05/05/26 |
| High | 19.75 on 02/18/21 | 212.71 on 02/18/26 | 421.79 on 08/11/26 | 156.95 on 02/13/26 | 546.17 on 08/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 384,691 | 246,206,640 | 223,983,840 | 168,348,672 | 134,427,824 |
| Shares Outstanding, K | 19,478 | 1,550,908 | 540,632 | 1,239,955 | 253,805 |
| Annual Sales, $M | 340,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income, $M | -49,980,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Qtr Sales, $M | 30,000 | 15,384,000,000 | 10,054,000,000 | 7,803,000,000 | 3,333,900,000 |
| Last Qtr Income, $M | -17,040,000 | 2,507,000,000 | 2,375,000,000 | -10,496,000,000 | 1,099,800,000 |
| 60-Month Beta | 1.17 | 0.26 | 0.41 | 0.32 | 0.30 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.63 on 07/27/26 | 6.29 on 08/04/26 | -6.75 on 08/04/26 | 4.73 on 08/03/26 |
| Latest Earnings Date | 02/26/21 | 11/05/26 | 11/03/26 | 10/29/26 | 11/02/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | N/A |
| Next Ex-Dividend Date | N/A | 02/20/26 | 08/21/26 | 09/15/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.67 | 18.65 | 0.00 | 30.78 |